Rothschild Investment LLC Decreases Holdings in DaVita Inc. (NYSE:DVA)

Rothschild Investment LLC trimmed its stake in DaVita Inc. (NYSE:DVA) by 1.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 11,865 shares of the company’s stock after selling 176 shares during the period. Rothschild Investment LLC’s holdings in DaVita were worth $1,774,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Transcendent Capital Group LLC purchased a new stake in shares of DaVita in the 3rd quarter valued at about $25,000. Blue Trust Inc. increased its position in DaVita by 56.4% during the third quarter. Blue Trust Inc. now owns 330 shares of the company’s stock worth $54,000 after buying an additional 119 shares during the period. Quarry LP purchased a new stake in DaVita in the third quarter valued at approximately $60,000. Venturi Wealth Management LLC boosted its holdings in shares of DaVita by 59.8% in the fourth quarter. Venturi Wealth Management LLC now owns 406 shares of the company’s stock valued at $61,000 after acquiring an additional 152 shares during the period. Finally, Versant Capital Management Inc grew its position in shares of DaVita by 58.7% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $68,000 after acquiring an additional 169 shares during the last quarter. Hedge funds and other institutional investors own 90.12% of the company’s stock.

DaVita Price Performance

DVA stock opened at $141.96 on Tuesday. The firm has a 50 day moving average of $160.86 and a 200-day moving average of $158.19. The company has a market cap of $11.36 billion, a price-to-earnings ratio of 13.22, a PEG ratio of 1.07 and a beta of 0.94. The company has a current ratio of 1.26, a quick ratio of 1.21 and a debt-to-equity ratio of 23.18. DaVita Inc. has a 12-month low of $124.42 and a 12-month high of $179.60.

DaVita (NYSE:DVA) last posted its earnings results on Thursday, February 13th. The company reported $2.24 EPS for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. As a group, equities analysts expect that DaVita Inc. will post 10.76 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on DVA. Cowen reiterated a “hold” rating on shares of DaVita in a research note on Tuesday, February 18th. Barclays increased their target price on shares of DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 18th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, DaVita has a consensus rating of “Hold” and a consensus price target of $162.80.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.